FILANA THERAPEUTICS, INC. - Common Stock (SAVA)

CUSIP: 14817C107

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock
Shares outstanding
48,331,225
Total 13F shares
15,768,881
Share change
-1,527,745
Total reported value
$23,653,533
Put/Call ratio
63%
Price per share
$1.50
Number of holders
114
Value change
-$3,650,996
Number of buys
42
Number of sells
77

Quarterly Holders Quick Answers

What is CUSIP 14817C107?
CUSIP 14817C107 identifies SAVA - FILANA THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FILANA THERAPEUTICS, INC. - Common Stock (SAVA) as of Q1 2025

As of 31 Mar 2025, FILANA THERAPEUTICS, INC. - Common Stock (SAVA) was held by 114 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 15,768,881 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA ADVISERS, LP, STATE STREET CORP, JPMORGAN CHASE & CO, SUSQUEHANNA INTERNATIONAL GROUP, LLP, UBS Group AG, GOLDMAN SACHS GROUP INC, and GMT CAPITAL CORP. This page lists 114 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.